Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.800
-0.290 (-7.09%)
Nov 13, 2026, 4:00 PM EST - Market closed

Camp4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
238318105--
Market Cap Growth
15.87%202.65%---
Enterprise Value
120249274--
Last Close Price
3.806.135.22--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
44.8290.92161.17--
PB Ratio
2.236.671.66--
P/TBV Ratio
2.236.671.66--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
22.6371.22420.77--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.060.040.140.320.15
Net Debt / Equity Ratio
-1.10-2.25-0.88-0.68-0.84
Net Debt / EBITDA Ratio
2.322.131.080.521.60
Net Debt / FCF Ratio
4.473.601.200.581.66
Asset Turnover
0.050.040.010.00-
Quick Ratio
6.287.076.684.9710.56
Current Ratio
6.427.356.925.1310.62
Return on Equity (ROE)
-146.12%-145.07%-101.99%-80.13%-
Return on Assets (ROA)
-29.92%-33.18%-49.80%-41.17%-
Return on Capital Employed (ROCE)
-46.20%-50.90%-77.30%-110.10%-47.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-51.22%-25.28%-49.29%--
FCF Yield
-11.07%-9.38%-43.78%--
Buyback Yield / Dilution
-193.11%-547.76%-1087.44%-26.47%-
SEC Filings: 10-K · 10-Q